Lineage Cell Therapeutics In shares owned by Tower Research Capital
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.4k | 972 | 1.48 |
| 2023-09-30 | $12k | 10k | 1.18 |
| 2023-06-30 | $11k | 8.0k | 1.41 |
| 2023-03-31 | $15k | 10k | 1.54 |
| 2022-12-31 | $0 | 11k | 0.00 |
| 2022-09-30 | $0 | 302 | 0.00 |
| 2022-06-30 | $0 | 202 | 0.00 |
| 2022-03-31 | $0 | 7.9k | 0.00 |
| 2021-12-31 | $0 | 7.8k | 0.00 |
| 2021-09-30 | $0 | 3.6k | 0.00 |
| 2021-06-30 | $43k | 8.6k | 5.00 |
| 2021-03-31 | $0 | 200 | 0.00 |
| 2020-09-30 | $14k | 15k | 0.91 |
| 2020-06-30 | $36k | 41k | 0.87 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital